Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit

BACKGROUND: Although neonates and young infants with cholestasis are commonly treated with either phenobarbital or ursodeoxycholic acid (ursodiol), there is no evidence that phenobarbital is effective for this indication. Our objective was to compare the effectiveness of ursodiol and phenobarbital f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Tamorah, Kuye, Simisola, Sherman, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011596/
https://www.ncbi.nlm.nih.gov/pubmed/29925342
http://dx.doi.org/10.1186/s12887-018-1167-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011596/
https://www.ncbi.nlm.nih.gov/pubmed/29925342
http://dx.doi.org/10.1186/s12887-018-1167-y

Ejemplares similares